Influence of heptral on the condition of the liver tissue after its resection


Cite item

Full Text

Abstract

In experiments on 37 rabbits studied the influence of a controlled ischemia of the liver on its morphology and function when
administered heptral, belonging to the pharmacological group hepatoprotectors. Three series of experiments with ligation
hepatoduodenal ligament for 20 and 30 minutes and resection of the left outer lobe of the liver. It is shown that operation
without the introduction of heptral are accompanied by increased content of lipid peroxidation (LPO) in liver tissue at the
same time there are pronounced structural changes. Established that heptral reduces the severity of structural and functional
changes in the liver in conditions of prolonged ischemia body up to 30 minutes, has antioxidant properties, helping to reduce
the intensity of the processes LPO

About the authors

Орловский государственный университет

Author for correspondence.
Email: author@vestnik-surgery.com

д.м.н., проф., зав.
кафедрой оперативной хирургии и топографиче-ской анатомии с курсом факультетской хирургии
медицинского института Орловского государствен-ного университета, заслуженный деятель науки РФ,
академик АМТН РФ; e-mail:anperkov@yandex.ru

Орловский государственный университет

Email: author@vestnik-surgery.com

к.м.н., соискатель
кафедры оперативной хирургии и топографической
анатомии с курсом факультетской хирургии меди-цинского института Орловского государственного
университета; e-mail: anperkov@yandex.ru

Орловский государственный университет

Email: author@vestnik-surgery.com

к.м.н., старший пре-подаватель кафедры пропедевтики Курского госу-дарственного медицинского университета; e-mail:
anperkov@yandex.ru

References

  1. Bilenko M.V. Teoreticheskie i eksperimental'nye obo-snovaniia primeneniia antioksidantnoi terapii dlia
  2. profilaktiki ostrykh ishemicheskikh povrezhdenii v
  3. organakh [Theoretical and experimental-warping about the use of antioxidant therapy for
  4. prevention of acute ischemic lesions in
  5. bodies]. V kn: Bioantiokisliteli v reguliatsii meta-bolizma v norme i patologii [Bioantiokislitels in the regulation of metabolism in health and disease]. M.: Meditsina. 1982; 195-213.
  6. Bilenko M.V. Ishemicheskoe i reperfuzionnoe povrezh-denie or-ganov. V kn: Molekuliarnye mekhanizmy i puti
  7. preduprezhdeniia i lecheniia [Ischemic and reperfusion damage to organs. In: Molecular mechanisms and ways of
  8. prevention and treatment]. M.: Meditsina. 1989; 157.
  9. Boldyrev A.A. Okislitel'nyi stress i mozg [Oxidative stress and the brain]. Sorosov-skii obrazovatel'nyi zhurnal. 2001; 7: 21-27.
  10. Veronskii G.I. O metodakh rezektsii pecheni [On the methods of liver resection]. Annaly
  11. khirurgicheskoi gepatologii. 2006; 11: 1: 85-88.
  12. Vishnevskii V.A., Kubyshkin V.A., Chzhao A.V., Ikramov
  13. R.Z. Operatsii na pecheni. Rukovodstvo dlia khirurgov [Operations on the liver. Guide for Surgeons].
  14. M.: Miklosh. 2003; 156.
  15. Gorbakov V.V., Kalinin A.V., Galik V.P., Karshieva A.V.
  16. Geptral– novoe sredstvo lecheniia diffuznykh zabole-vanii pecheni [Geptral - new treatment of diffuse liver zabole-ments]. Ros. zhurn. gastroenterolog., gepatol.,
  17. koloproktol. 1998; 8: 4: 98-102.
  18. Zenkov N.K., Lankin V.Z., Men'shchikova E.B. Okislitel'-nyi stress. Biokhimicheskii i patofiziologicheskie
  19. aspekty [Oxidative stress. The biochemical and pathophysiological
  20. Aspects]. M.: MAIK«Nauka/Interperiodika». 2001;
  21. Kamyshnikov V.S. Spravochnik po kliniko-biokhimiche-skoi laboratornoi diagnostike(v2-kh tomakh) [Handbook of clinical and biochemical laboratory diagnostics (c2 volumes)]. Minsk.
  22. ; 463.
  23. Kurpatov V.I., Kurpatova N.P. Primenenie antide-pressantov v obshchemeditsinskoi praktike [The use of antidepressants in general practice]. Terra Medica.
  24. ; 3: 23-25.
  25. Panin L.E., Shalbueva N.I., Maksimov V.F., Poliakov
  26. L.M. i dr. Strukturnye izmeneniia i osobennosti okis-litel'nogo fosforilirovaniia v mitokhondriiakh pecheni [Structural changes and features-oxides-inflammatory phosphorylation in the mitochondria of liver]
  27. krys liniiOXYS. Biol. membrany. 2004; 1: 21: 32–37.
  28. Iakovenko E.P., Grigor'ev P.Ia., Agafonova N.A. i dr.
  29. Vnutripechenochnyi kholestaz– ot patogeneza k leche-niiu [Intrahepatic holestaz- from pathogenesis to treatment]. Praktikuiushchii vrach. 1998; 13: 2: 20-24.
  30. Berk P.D., Jansen P.L.M. Pechenochnye transportery, pechenochnyi
  31. transport i ego zabolevaniia [Hepatic transporters, hepatic
  32. transport and its diseases]. Semin. Liver Dis. 2000; 20: 247-408.
  33. Kokevling F., Schwartz S.I. Khirurgiya pecheni [Liver surgery]. GmbH. 2001;
  34. Volff A.A., Rotmensch H.H., Stanley W.C., Ferrari R.
  35. Metabolicheskiy podkhody k lecheniyu ishemicheskoy bolezni serdtsa
  36. bolezni: perspektiva klinitsista. Serdechnyy Otzyvy [Metabolic approaches to the treatment of ischemic heart
  37. disease: the clinicans perspective. Heart Failure Reviews].
  38. ; 7: 187-203.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies